haloperidol has been researched along with Atrophy in 17 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebral cortical gray was examined volumetrically in 19 patients with schizophrenia before and following 28 days of treatment with two SGAs (risperidone and ziprasidone; n = 13) or a FGA (haloperidol; n = 6)." | 5.11 | Cerebral cortical gray expansion associated with two second-generation antipsychotics. ( Christensen, JD; Garver, DL; Holcomb, JA, 2005) |
| "Schizophrenia is a neurodevelopmental disorder associated with persistent symptomatology, severe functional disability, and residual morbidity characteristic of neurodegenerative brain diseases." | 1.34 | Neuroprotection: a therapeutic strategy to prevent deterioration associated with schizophrenia. ( Jarskog, LF; Lieberman, JA; Perkins, DO, 2007) |
| "Cranial magnetic resonance image (MRI) of the patient showed bilateral symmetric hyperintensity in the caudate nucleus and putamen." | 1.32 | Transient tic disorder following carbon monoxide poisoning. ( Alioglu, Z; Aynaci, M; Boz, C; Sari, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stiefelhagen, P | 1 |
| Vernon, AC | 1 |
| Crum, WR | 1 |
| Lerch, JP | 1 |
| Chege, W | 1 |
| Natesan, S | 1 |
| Modo, M | 1 |
| Cooper, JD | 1 |
| Williams, SC | 1 |
| Kapur, S | 1 |
| Konopaske, GT | 1 |
| Lange, N | 1 |
| Coyle, JT | 1 |
| Benes, FM | 1 |
| Alioglu, Z | 1 |
| Boz, C | 1 |
| Sari, A | 1 |
| Aynaci, M | 1 |
| Garver, DL | 2 |
| Holcomb, JA | 1 |
| Christensen, JD | 2 |
| Lieberman, JA | 1 |
| Perkins, DO | 1 |
| Jarskog, LF | 1 |
| Snider, SR | 1 |
| Factor, SA | 1 |
| Podskalny, GD | 1 |
| Barron, KD | 1 |
| Lawson, WB | 1 |
| Karson, CN | 1 |
| Mowadat, HR | 1 |
| Kerr, EE | 1 |
| StClair, D | 1 |
| Nair, TR | 1 |
| Holcomb, J | 1 |
| Ramberg, J | 1 |
| Kingsbury, S | 1 |
| Maruka, Y | 1 |
| Esumi, E | 1 |
| Kojima, S | 1 |
| van Kammen, DP | 1 |
| Peters, J | 1 |
| Yao, J | 1 |
| Neylan, T | 1 |
| Beuger, M | 1 |
| Pontius, E | 1 |
| O'Connor, DT | 1 |
| Lazarus, A | 1 |
| Smith, RC | 1 |
| Baumgartner, R | 1 |
| Ravichandran, GK | 1 |
| Largen, J | 1 |
| Calderon, M | 1 |
| Burd, A | 1 |
| Mauldin, M | 1 |
| Morihisa, JM | 1 |
| McAnulty, GB | 1 |
| Walsh, AC | 1 |
| Walsh, BH | 1 |
1 review available for haloperidol and Atrophy
| Article | Year |
|---|---|
Cerebellar pathology in schizophrenia--cause or consequence?
Topics: Animals; Apomorphine; Atrophy; Behavior, Animal; Brain Stem; Cats; Cerebellar Diseases; Cerebellum; | 1982 |
2 trials available for haloperidol and Atrophy
| Article | Year |
|---|---|
Cerebral cortical gray expansion associated with two second-generation antipsychotics.
Topics: Adult; Antipsychotic Agents; Atrophy; Cerebral Cortex; Cognition Disorders; Female; Follow-Up Studie | 2005 |
Atrophic and static (neurodevelopmental) schizophrenic psychoses: premorbid functioning, symptoms and neuroleptic response.
Topics: Adult; Aging; Alcohol Drinking; Algorithms; Antipsychotic Agents; Atrophy; Brain; Cerebral Ventricle | 1999 |
14 other studies available for haloperidol and Atrophy
| Article | Year |
|---|---|
[In process].
Topics: Antipsychotic Agents; Atrophy; Brain; Cerebral Cortex; Dopamine; Dose-Response Relationship, Drug; G | 2016 |
Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology.
Topics: Animals; Antipsychotic Agents; Astrocytes; Atrophy; Benzodiazepines; Cell Count; Cerebral Cortex; Ha | 2014 |
Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.
Topics: Animals; Atrophy; Bipolar Disorder; Case-Control Studies; Clozapine; Dendritic Spines; Female; Front | 2014 |
Transient tic disorder following carbon monoxide poisoning.
Topics: Atrophy; Carbon Monoxide Poisoning; Caudate Nucleus; Child; Dominance, Cerebral; Follow-Up Studies; | 2004 |
Neuroprotection: a therapeutic strategy to prevent deterioration associated with schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Atrophy; Benzodiazepines; Cerebral Cortex; Child; Cognition | 2007 |
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report.
Topics: Adult; AIDS Dementia Complex; Antipsychotic Agents; Astrocytes; Atrophy; Brain; Cell Count; Dystonia | 1994 |
Clinical correlates of body weight changes in schizophrenia.
Topics: Adult; Atrophy; Brain; Cerebral Ventricles; Energy Intake; Female; Haloperidol; Humans; Male; Psychi | 1994 |
Sporadic Pick's disease in a 28-year-old woman.
Topics: Adult; Atrophy; Carbamazepine; Dementia; Electroconvulsive Therapy; Female; Frontal Lobe; Haloperido | 1993 |
Tandospirone, a promising alternative drug in the treatment of chorea.
Topics: Animals; Atrophy; Cerebral Cortex; Chorea; Dementia; Dopamine Antagonists; Female; Fluvoxamine; Halo | 2000 |
CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
Topics: Adult; Arousal; Atrophy; Brain; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Human | 1991 |
EPS, NMS, and AIDS.
Topics: Adult; AIDS Dementia Complex; Atrophy; Cerebral Cortex; Dyskinesia, Drug-Induced; Haloperidol; Human | 1990 |
Cortical atrophy and white matter density in the brains of schizophrenics and clinical response to neuroleptics.
Topics: Adult; Antipsychotic Agents; Atrophy; Cerebral Cortex; Female; Haloperidol; Humans; Male; Middle Age | 1987 |
Structure and function: brain electrical activity mapping and computed tomography in schizophrenia.
Topics: Adult; Atrophy; Brain; Brain Mapping; Cerebral Ventricles; Delta Rhythm; Electroencephalography; Evo | 1985 |
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.
Topics: Adult; Aged; Anticoagulants; Anxiety; Atrophy; Brain Diseases; Dementia; Dicumarol; Fear; Female; Ha | 1974 |